USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
IMAGING BIOMETRICS, LLC
Address:
13416 Watertown Plank Road
Suite 260
ELM GROVE, WI 53122-
Phone:
N/A
URL:
N/A
EIN:
156263316
DUNS:
792265121
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $214,000.00 2
SBIR Phase II $797,331.00 1
STTR Phase I $105,081.00 1

Award List:

Development of the Standard for Clinical Breast Perfusion Imaging

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$107,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Currently detection of breast tumors is most often accomplished with x-ray mammography. This is true despite the fact that mammography misses 5-15% of palpable breast cancers and has a positive predictive value of only 15-30%. Consequently, mammography requires… More

Product Development of a a Brain Tumor Perfusion Imaging Technology

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$107,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Primary brain tumors are the leading cause of cancer-related deaths in children and the fourth leading cause of cancer-related deaths in people under the age of 54. Recently, a significant increase in the incidence of b rain tumors has been observed in people… More

Product Development of a Brain Tumor Perfusion Imaging Technology

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$797,331.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase II SBIR proposal is to expand upon the research and development efforts, begun in Phase I, with new enhancements and product offerings, while also taking the initial steps to position the Company for a multi-center clinical trial, planned… More

Automating MRI Delta T1 Methods for the Routine Assessment of Brain Tumor Burden

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$105,081.00
Agency:
HHS
Principal Investigator:
Kathleen M. Schmainda – 414-456-4051
Research Institution:
MEDICAL COLLEGE OF WISCONSIN
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): Contrast enhancement on MRI (magnetic resonance imaging) provides the best currently available approach for measuring tumor response to therapy in brain and other solid tumors. Accordingly, criteria have been formulated, by international committees, to guide the… More